Login / Signup

Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors.

Robert A KlonerColeman GrossJinwei YuanAnsgar ConradPablo E Pergola
Published in: Journal of cardiovascular pharmacology and therapeutics (2018)
Patiromer was effective and generally well-tolerated for hyperkalemia treatment, whether or not patients were taking RAAS inhibitors.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • replacement therapy